Profile
| Metric | Value |
|---|---|
| Full Name | Panbela Therapeutics, Inc. |
| Ticker | NASDAQ: PBLA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | panbela.com |
| Employees | 7 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $0.00 | |
| Price, 1D Change | 0.00% | |
| $4,855 | ||
| - | ||
| - | ||
| 7.56 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$232.43 | ||
| EPS, 1Y Change | +99.43% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | N/A | N/A |
| Last Ticker Change | SNBP | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$232.43 | ||
| EPS Estimate | N/A | - |
| EPS Est. Change | N/A | - |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $0.00 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$203.86 | -$232.43 | -14.01% | |
| - | N/A | - | |
| -$5.66 | N/A | +97.56% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $0.00 | |
| $0.13 | ||
| SMA 200 vs Price | +13,180.00% | |
| $0.01 | ||
| SMA 50 vs Price | +920.00% | |
| 7.56 | ||
| $0.00 | ||
| 37.50 | ||
| 32.33% | ||
| 11.85% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$232.43 | ||
| $0.00 | ||
| - | ||
| -$25.65M | ||
| - | ||
| -$25.26M | ||
| - | ||
| -$25.65M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| -1.10 | ||
| 0.25 | ||
| 0.25 | ||
| - | ||
| - | ||
| -23.00 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.00 | ||
| -0.22 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| -$4.71M | ||
| $2.58M | ||
| $11.80M | ||
| $3.06M | ||
| $16.51M | ||
| $12.32M | ||
| $5.19M | ||
| $1.00M | ||
| $9.94M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $25.26M | ||
| $25.65M | ||
| $0.00 | ||
| $5.03M | ||
| - | ||
| $0.00 | ||
| -$186.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$25.25M | ||
| $400.00K | ||
| $26.14M | ||
| $0.00 | ||
| -$25.25M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | ||
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Roth MKM | → | |
| Roth MKM | → | |
| Roth MKM | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with PBLA
Data Sources & References
- PBLA Official Website www.panbela.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1029125/000143774924035315/0001437749-24-035315-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1029125/000143774924009418/0001437749-24-009418-index.htm
- PBLA Profile on Yahoo Finance finance.yahoo.com/quote/PBLA
- PBLA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pbla
FAQ
What is the ticker symbol for Panbela Therapeutics, Inc.?
The ticker symbol for Panbela Therapeutics, Inc. is NASDAQ:PBLA
Does Panbela Therapeutics, Inc. pay dividends?
No, Panbela Therapeutics, Inc. does not pay dividends
What sector is Panbela Therapeutics, Inc. in?
Panbela Therapeutics, Inc. is in the Healthcare sector
What industry is Panbela Therapeutics, Inc. in?
Panbela Therapeutics, Inc. is in the Biotechnology industry
What country is Panbela Therapeutics, Inc. based in?
Panbela Therapeutics, Inc. is headquartered in United States
When did Panbela Therapeutics, Inc. go public?
Panbela Therapeutics, Inc. initial public offering (IPO) was on January 3, 2017
Is Panbela Therapeutics, Inc. in the S&P 500?
No, Panbela Therapeutics, Inc. is not included in the S&P 500 index
Is Panbela Therapeutics, Inc. in the NASDAQ 100?
No, Panbela Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Panbela Therapeutics, Inc. in the Dow Jones?
No, Panbela Therapeutics, Inc. is not included in the Dow Jones index
When was Panbela Therapeutics, Inc. last earnings report?
Panbela Therapeutics, Inc.'s most recent earnings report was on July 23, 2025
When does Panbela Therapeutics, Inc. report earnings?
The date for Panbela Therapeutics, Inc.'s next earnings report has not been announced yet